Skip to content

Exelixis EXEL Investing Cash Flow

Investing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
-$3.92B-16.8%
Pfizer logo
PfizerPFE
$785M-76.0%
Summit Therapeutics logo
Summit TherapeuticsSMMT
-$238K-100%
Incyte logo
IncyteINCY
-$88.2M-8,140%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$536.82M+215%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$42.74M-2,579%

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's investing cash flow?
Exelixis (EXEL) reported investing cash flow of -$51.07M in Q1 2026.
How has Exelixis's investing cash flow changed year-over-year?
Exelixis's investing cash flow decreased by 202.6% year-over-year, from $49.76M to -$51.07M.
What is the long-term trend for Exelixis's investing cash flow?
Over 3 years (2021 to 2025), Exelixis's investing cash flow has grown at a 101.4% compound annual growth rate (CAGR), from -$42.88M to $350.44M.
What does investing cash flow mean?
The net cash flow from buying or selling long-term assets and investments.
How do you interpret investing cash flow?
Negative values typically indicate reinvestment into the business or strategic acquisitions, while positive values may result from the sale of assets or the maturity of investment portfolios.
How does investing cash flow compare across companies?
Commonly fluctuates based on M&A activity and investment strategy; peers often show negative values during periods of heavy R&D infrastructure investment.